GENEVIEVE BERARDUCCI: Open Payments
NPI 1073203667 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$511 in 19 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $86 · 2025 $511
Food & beverage: $511
| Company | Payments | Amount |
|---|---|---|
| BeOne Medicines USA, Inc. | 1 | $131 |
| GENZYME CORPORATION | 2 | $49 |
| Merck Sharp & Dohme LLC | 2 | $44 |
| PFIZER INC. | 2 | $41 |
| Janssen Biotech, Inc. | 2 | $38 |
| Geron Corporation | 1 | $27 |
| KYOWA KIRIN, INC. | 1 | $26 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| SOBI, INC | 1 | $21 |
Products named: BRUKINSA, ZERBAXA, ELREXFIO, SARCLISA, RYTELO, POTELIGEO, Vanflyta, ICLUSIG.
Industry payments across CO — which companies pay providers there.
